{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:16:53Z","timestamp":1787890613374,"version":"build-2784847793"},"reference-count":51,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Vet Comparative Oncology"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are endogenous methylated arginine derivatives associated with endothelial dysfunction and tumour progression in humans. Their relevance in canine oncology remains unclear. This prospective study aimed to assess plasma concentrations of ADMA and SDMA in dogs newly diagnosed with large cell lymphoma or non\u2010cutaneous hemangiosarcoma (HSA); dogs with benign splenic lesions were also enrolled. Renal function was assessed at the time of inclusion to exclude overt kidney disease. Plasma ADMA and SDMA concentrations were measured at diagnosis, and clinical staging data were collected. A total of 31 dogs were enrolled: 11 with lymphoma, 15 with HSA and 5 with benign splenic lesions. SDMA concentrations exceeded the reference interval in 47%, 36% and 0% of dogs with HSA, lymphoma and benign lesions, respectively. Dogs with lymphoma (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003) and HSA (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.013) had significantly higher SDMA concentrations than dogs with benign splenic lesions. Moreover, dogs with presumed disseminated HSA had significantly higher SDMA concentrations than those without metastatic disease (median: 21.5 vs. 12\u2009\u03bcg\/dL;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.012). In contrast, plasma ADMA concentrations did not differ significantly among groups (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.39). These findings suggest that lymphoma and HSA may represent extra\u2010renal causes of SDMA elevation in dogs, and that SDMA could have value as a biomarker of tumour burden or progression. The potential clinical utility of ADMA in canine cancer warrants further investigation.\n                  <\/jats:p>","DOI":"10.1111\/vco.70108","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:23:51Z","timestamp":1787887431000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma Dimethylarginine Concentrations in Dogs With Large Cell Lymphoma or Hemangiosarcoma: A Prospective Observational Study"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3594-6191","authenticated-orcid":false,"given":"Gr\u00e9goire Bernardo","family":"Marques","sequence":"first","affiliation":[{"name":"\u00c9cole Nationale V\u00e9t\u00e9rinaire d'Alfort, Service de M\u00e9decine Interne  Maisons\u2010Alfort France"},{"name":"Universit\u00e9 de Lyon, VetAgro Sup, Service de canc\u00e9rologie, UR ICE  Marcy l'Etoile France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Maurey","sequence":"additional","affiliation":[{"name":"\u00c9cole Nationale V\u00e9t\u00e9rinaire d'Alfort, Service de M\u00e9decine Interne  Maisons\u2010Alfort France"},{"name":"UMR1161 Virologie, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d'Alfort, ANSES, Universit\u00e9 Paris\u2010Est  Maisons\u2010Alfort France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3252-9155","authenticated-orcid":false,"given":"Delphine","family":"Le Roux","sequence":"additional","affiliation":[{"name":"Anses, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d'Alfort, Laboratoire de Sant\u00e9 Animale, BIPAR  Maisons\u2010Alfort France"},{"name":"\u00c9cole Nationale V\u00e9t\u00e9rinaire d'Alfort, BioP\u00f4le, Service Infectiologie\u2014Secteur Immunologie\u2010Bact\u00e9riologie  Maisons\u2010Alfort France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2400-8309","authenticated-orcid":false,"given":"J\u00e9r\u00e9my","family":"B\u00e9guin","sequence":"additional","affiliation":[{"name":"\u00c9cole Nationale V\u00e9t\u00e9rinaire d'Alfort, Service de M\u00e9decine Interne  Maisons\u2010Alfort France"},{"name":"UMR1161 Virologie, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d'Alfort, ANSES, Universit\u00e9 Paris\u2010Est  Maisons\u2010Alfort France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"6","key":"e_1_2_13_2_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.phrs.2009.10.001","article-title":"Asymmetric Dimethylarginine: Understanding the Physiology, Genetics, and Clinical Relevance of This Novel Biomarker. Proceedings of the 4th International Symposium on ADMA","volume":"60","author":"B\u00f6ger R. H.","year":"2009","journal-title":"Pharmacological Research"},{"issue":"10","key":"e_1_2_13_3_1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","article-title":"The Regulation, Functions and Clinical Relevance of Arginine Methylation","volume":"20","author":"Guccione E.","year":"2019","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"1","key":"e_1_2_13_4_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","article-title":"Arginine Methylation: The Coming of Age","volume":"65","author":"Blanc R. S.","year":"2017","journal-title":"Molecular Cell"},{"issue":"11","key":"e_1_2_13_5_1","doi-asserted-by":"crossref","DOI":"10.3390\/life11111147","article-title":"Structure, Activity, and Function of PRMT1","volume":"11","author":"Thiebaut C.","year":"2021","journal-title":"Life"},{"issue":"11","key":"e_1_2_13_6_1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00018-015-1847-9","article-title":"The PRMT5 Arginine Methyltransferase: Many Roles in Development, Cancer and Beyond","volume":"72","author":"Stopa N.","year":"2015","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"e_1_2_13_7_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc3409","article-title":"Protein Arginine Methyltransferases and Cancer","volume":"13","author":"Yang Y.","year":"2013","journal-title":"Nature Reviews. Cancer"},{"issue":"1","key":"e_1_2_13_8_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein Arginine Methylation in Mammals: Who, What, and Why","volume":"33","author":"Bedford M. T.","year":"2009","journal-title":"Molecular Cell"},{"issue":"11","key":"e_1_2_13_9_1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molmed.2019.05.007","article-title":"PRMTs and Arginine Methylation: Cancer's Best\u2010Kept Secret?","volume":"25","author":"Jarrold J.","year":"2019","journal-title":"Trends in Molecular Medicine"},{"issue":"5","key":"e_1_2_13_10_1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein Arginine Methyltransferases: Promising Targets for Cancer Therapy","volume":"53","author":"Hwang J. W.","year":"2021","journal-title":"Experimental & Molecular Medicine"},{"issue":"3","key":"e_1_2_13_11_1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ijc.25366","article-title":"Dysregulation of PRMT1 and PRMT6, Type I Arginine Methyltransferases, Is Involved in Various Types of Human Cancers","volume":"128","author":"Yoshimatsu M.","year":"2011","journal-title":"International Journal of Cancer"},{"issue":"5","key":"e_1_2_13_12_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250839","article-title":"Validation of Protein Arginine Methyltransferase 5 (PRMT5) as a Candidate Therapeutic Target in the Spontaneous Canine Model of Non\u2010Hodgkin Lymphoma","volume":"16","author":"Sloan S. L.","year":"2021","journal-title":"PLoS One"},{"key":"e_1_2_13_13_1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5604\/17322693.1203720","article-title":"Elevated Plasma ADMA Contributes to Development of Endothelial Dysfunction in Children With Acute Lymphoblastic Leukemia","volume":"70","author":"Doroszko A.","year":"2016","journal-title":"Post\u0119py Higieny i Medycyny Do\u015bwiadczalnej"},{"issue":"12","key":"e_1_2_13_14_1","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1080\/10428190802510323","article-title":"Asymmetric Dimethylarginine in Hematological Malignancies: A Preliminary Study","volume":"49","author":"Szuba A.","year":"2008","journal-title":"Leukemia & Lymphoma"},{"issue":"5","key":"e_1_2_13_15_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197148","article-title":"Asymmetric and Symmetric Dimethylarginines and Mortality in Patients With Hematological Malignancies\u2010A Prospective Study","volume":"13","author":"Chachaj A.","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"e_1_2_13_16_1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/jvim.12835","article-title":"Symmetric Dimethylarginine Assay Validation, Stability, and Evaluation as a Marker for the Early Detection of Chronic Kidney Disease in Dogs","volume":"29","author":"Nabity M. B.","year":"2015","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"3","key":"e_1_2_13_17_1","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/jvim.13942","article-title":"Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs With Naturally Occurring Chronic Kidney Disease","volume":"30","author":"Hall J. A.","year":"2016","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"3","key":"e_1_2_13_18_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jvim.14694","article-title":"Plasma Symmetric Dimethylarginine Concentration in Dogs With Acute Kidney Injury and Chronic Kidney Disease","volume":"31","author":"Dahlem D. P.","year":"2017","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"e_1_2_13_19_1","unstructured":"M.Yerramilli M.Yerramilli G.Farace J.Robertson andR.Relford \u201cSymmetric Dimethylarginine (SDMA) as Kidney Biomarker in Canine and Feline Cancer \u201dposter presented at 26th ECVIM\u2010CA Annual Congress Goteborg Sweden September 8 (2016)."},{"key":"e_1_2_13_20_1","unstructured":"A.Abrams\u2010Ogg B.Rutland P.Levis et\u00a0al. \u201cLymphoma and Symmetric Dimethylarginine Concentration in Dogs: A Preliminary Study \u201dpaper presented at 2017 ACVIM Forum National Harbor MD June 8 (2017)."},{"issue":"4","key":"e_1_2_13_21_1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/vco.12845","article-title":"The Association Between Symmetric Dimethylarginine Concentrations and Various Neoplasms in Dogs and Cats","volume":"20","author":"Coyne M. J.","year":"2022","journal-title":"Veterinary and Comparative Oncology"},{"issue":"2","key":"e_1_2_13_22_1","doi-asserted-by":"crossref","DOI":"10.1111\/jvim.70015","article-title":"Influence of Carcinoma and Sarcoma on Neutrophil Gelatinase\u2010Associated Lipocalin and Symmetric Dimethylarginine Concentrations in Dogs","volume":"39","author":"Rixon A.","year":"2025","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"4","key":"e_1_2_13_23_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1567-5688(03)00027-8","article-title":"Asymmetric Dimethylarginine (ADMA): A Key Regulator of Nitric Oxide Synthase","volume":"4","author":"B\u00f6ger R. H.","year":"2003","journal-title":"Atherosclerosis. Supplements"},{"issue":"1","key":"e_1_2_13_24_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of l\u2010Arginine Analogues With l\u2010Arginine Transport Mediated by the y+ Carrier hCAT\u20102B","volume":"1","author":"Closs E. I.","year":"1997","journal-title":"Nitric Oxide"},{"issue":"2","key":"e_1_2_13_25_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semnephrol.2014.02.003","article-title":"Dimethylarginines ADMA and SDMA: The Real Water\u2010Soluble Small Toxins?","volume":"34","author":"Schepers E.","year":"2014","journal-title":"Seminars in Nephrology"},{"issue":"4","key":"e_1_2_13_26_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1567-5688(03)00030-8","article-title":"ADMA: A Novel Risk Factor That Explains Excess Cardiovascular Event Rate in Patients With End\u2010Stage Renal Disease","volume":"4","author":"B\u00f6ger R. H.","year":"2003","journal-title":"Atherosclerosis. Supplements"},{"issue":"11","key":"e_1_2_13_27_1","doi-asserted-by":"crossref","first-page":"e0165811","DOI":"10.1371\/journal.pone.0165811","article-title":"Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta\u2010Analysis of Prospective Studies","volume":"11","author":"Schlesinger S.","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"e_1_2_13_28_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jmv.2011.12.135","article-title":"La Dysfonction Endoth\u00e9liale: Caract\u00e9risation, M\u00e9canismes Impliqu\u00e9s et Cons\u00e9quences Potentielles Sur la Fonction Vasculaire","volume":"37","author":"Schini\u2010Kerth V.","year":"2012","journal-title":"Journal Des Maladies Vasculaires"},{"issue":"3","key":"e_1_2_13_29_1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.rvsc.2005.07.005","article-title":"Body Size, but Neither Age nor Asymptomatic Mitral Regurgitation, Influences Plasma Concentrations of Dimethylarginines in Dogs","volume":"80","author":"Pedersen L. G.","year":"2006","journal-title":"Research in Veterinary Science"},{"issue":"3","key":"e_1_2_13_30_1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbrc.2008.10.080","article-title":"Variance of DDAH\/PRMT\/ADMA Pathway in Atrial Fibrillation Dogs","volume":"377","author":"Liu H.","year":"2008","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"e_1_2_13_31_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238440","article-title":"Symmetric Dimethylarginine in Dogs With Myxomatous Mitral Valve Disease at Various Stages of Disease Severity","volume":"15","author":"Valente C.","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"e_1_2_13_32_1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/jvim.15785","article-title":"Evaluation of Asymmetric Dimethylarginine as an Inflammatory and Prognostic Marker in Dogs With Acute Pancreatitis","volume":"34","author":"Gori E.","year":"2020","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"1","key":"e_1_2_13_33_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchromb.2006.07.024","article-title":"HPLC Analysis of ADMA and Other Methylated l\u2010Arginine Analogs in Biological Fluids","volume":"851","author":"Teerlink T.","year":"2007","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"12","key":"e_1_2_13_34_1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1515\/CCLM.2004.257","article-title":"Determination of Asymmetric Dimethylarginine (ADMA) Using a Novel ELISA Assay","volume":"42","author":"Schulze F.","year":"2004","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"e_1_2_13_35_1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jchromb.2006.12.009","article-title":"Asymmetric Dimethylarginine\u2014Comparison of HPLC and ELISA Methods","volume":"850","author":"Siroka R.","year":"2007","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"e_1_2_13_36_1","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2021"},{"key":"e_1_2_13_37_1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham H.","year":"2016"},{"key":"e_1_2_13_38_1","volume-title":"TNM Classification of Tumours in Domestic Animals\/ Edited by L.N. Owen","author":"Owen L. N.","year":"1980"},{"issue":"3","key":"e_1_2_13_39_1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jvim.15488","article-title":"ACVIM Consensus Guidelines for the Diagnosis and Treatment of Myxomatous Mitral Valve Disease in Dogs","volume":"33","author":"Keene B. W.","year":"2019","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"3","key":"e_1_2_13_40_1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1600-0609.2001.5790493.x","article-title":"Kidney Involvement and Renal Manifestations in Non\u2010Hodgkin's Lymphoma and Lymphocytic Leukemia: A Retrospective Study in 700 Patients","volume":"67","author":"Da'as N.","year":"2001","journal-title":"European Journal of Haematology"},{"issue":"8","key":"e_1_2_13_41_1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jsap.12840","article-title":"Prevalence of Proteinuria in a Canine Oncology Population","volume":"59","author":"Prudic R. A.","year":"2018","journal-title":"Journal of Small Animal Practice"},{"issue":"1","key":"e_1_2_13_42_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jsap.12004.x","article-title":"Proteinuria in Canine Patients With Lymphoma","volume":"54","author":"Di Bella A.","year":"2013","journal-title":"Journal of Small Animal Practice"},{"key":"e_1_2_13_43_1","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1143532","article-title":"Protein Homeostasis in Aging and Cancer","volume":"11","author":"Chen X. Q.","year":"2023","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"5","key":"e_1_2_13_44_1","first-page":"1107","article-title":"Understanding Tumor Anabolism and Patient Catabolism in Cancer\u2010Associated Cachexia","volume":"7","author":"Schcolnik\u2010Cabrera A.","year":"2017","journal-title":"American Journal of Cancer Research"},{"issue":"3","key":"e_1_2_13_45_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tvjl.2015.03.024","article-title":"Big Endothelin\u20101 as a Tumour Marker for Canine Haemangiosarcoma","volume":"204","author":"Fukumoto S.","year":"2015","journal-title":"Veterinary Journal"},{"issue":"2","key":"e_1_2_13_46_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1939-1676.2001.tb01244.x","article-title":"Plasma Vascular Endothelial Growth Factor Concentrations in Healthy Dogs and Dogs With Hemangiosarcoma","volume":"15","author":"Clifford C. A.","year":"2001","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"6","key":"e_1_2_13_47_1","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","article-title":"Dimethylarginine Dimethylaminohydrolase (DDAH): Expression, Regulation, and Function in the Cardiovascular and Renal Systems","volume":"293","author":"Palm F.","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"4","key":"e_1_2_13_48_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10456-018-9617-6","article-title":"Assessment of the Direct Effects of DDAH I on Tumour Angiogenesis In\u00a0Vivo","volume":"21","author":"Papaevangelou E.","year":"2018","journal-title":"Angiogenesis"},{"issue":"1","key":"e_1_2_13_49_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10456-017-9587-0","article-title":"Dimethylarginine Dimethylaminohydrolase\u20101 (DDAH1) is Frequently Upregulated in Prostate Cancer, and Its Overexpression Conveys Tumor Growth and Angiogenesis by Metabolizing Asymmetric Dimethylarginine (ADMA)","volume":"21","author":"Reddy K. R. K.","year":"2018","journal-title":"Angiogenesis"},{"key":"e_1_2_13_50_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01455","article-title":"Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer","volume":"9","author":"Hulin J. A.","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"e_1_2_13_51_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.36401\/JIPO-22-1","article-title":"Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A Review","volume":"5","author":"Feustel K.","year":"2022","journal-title":"Journal of Immunotherapy and Precision Oncology"},{"issue":"3","key":"e_1_2_13_52_1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/13543784.2016.1144747","article-title":"Small Molecule Inhibitors of Protein Arginine Methyltransferases","volume":"25","author":"Hu H.","year":"2016","journal-title":"Expert Opinion on Investigational Drugs"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vco.70108","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vco.70108","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vco.70108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:24:19Z","timestamp":1787887459000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vco.70108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":51,"alternative-id":["10.1111\/vco.70108"],"URL":"https:\/\/doi.org\/10.1111\/vco.70108","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"2026-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"vco.70108"}}